Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -8,842 | -7,580 | N/A |
| Depreciation Amortization | 294 | 235 | N/A |
| Accounts payable and accrued liabilities | -361 | 463 | N/A |
| Other Working Capital | -428 | 747 | N/A |
| Other Operating Activity | 452 | -406 | 0 |
| Operating Cash Flow | $-8,885 | $-6,541 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -427 | -182 | N/A |
| Purchase Of Investment | -1,850 | N/A | N/A |
| Sale Of Investment | N/A | 1,324 | N/A |
| Other Investing Activity | -850 | 0 | 0 |
| Investing Cash Flow | $-3,127 | $1,142 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 1,000 | N/A |
| Debt Repayment | -4 | 2 | N/A |
| Common Stock Issued | 19 | 12 | N/A |
| Other Financing Activity | 17,915 | 21 | 0 |
| Financing Cash Flow | $17,930 | $1,035 | $N/A |
| Beginning Cash Position | 358 | 4,722 | N/A |
| End Cash Position | 6,276 | 358 | N/A |
| Net Cash Flow | $5,918 | $-4,364 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -8,885 | -6,541 | N/A |
| Capital Expenditure | -427 | -182 | N/A |
| Free Cash Flow | -9,312 | -6,723 | 0 |